Trial Profile
A retrospective, observational study of ustekinumab patients with moderate-to-severe psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 02 Feb 2016 New trial record